06/04/2026
Are you an adult who recently started buprenorphine treatment (such as Suboxone®) for Opioid Use Disorder? Researchers at Gibson Center for Behavioral Change are participating in a national research study to explore how the medication tirzepatide (Mounjaro® or Zepbound®) may impact treatment retention. Learn more about how you can participate and contribute to this important research.
If interested, please call/text (573) 948-8133 or email [email protected]. Information will be kept confidential.